Clinical endocannabinoid deficiency (CECD) is poorly understood. Anxiety and depression might be clinical markers of low levels of anandamide and 2-AG in the brain. By restoring levels of endocannabinoids with THC administration, stress-induced anxiety may be lowered. However, at which frequency and dose should THC be used to cope with stress-induced oxidation ?